AstraZeneca

AstraZeneca Will Soar On 2 New Drugs In 2013
Seeking Alpha
Thu, 06/21/12 - 05:54 pm
AstraZeneca
Bristol-Myers Squibb
JNJ
Eli Lilly
AZD4547
Merck
Sanofi
Dapagliflozin
AZ halts obesity drug trial, completes Ardea purchase
Pharma Times, UK
Wed, 06/20/12 - 12:32 pm
obesity
M&A
Ardea Biosciences
AstraZeneca
AZD2820
Merck: Can 5 New Drugs Fill Singulair Gap?
Seeking Alpha
Tue, 06/19/12 - 10:21 am
Merck
Singulair
Pfizer
AstraZeneca
Sanofi
Forest Labs
Bristol-Myers Squibb
suvorexant
Eli Lilly
Bridon
V503
Endocyte
Tredaptive
AstraZeneca, Rigel Pharmaceuticals sign license agreement for R256
Yahoo/Fly on the Wall
Tue, 06/19/12 - 10:13 am
Rigel Pharmaceuticals
AstraZeneca
R256
JAK inhibitors
Nektar Phase III Trials At Risk
Seeking Alpha
Mon, 06/18/12 - 02:44 pm
Nektar
NKTR-118
AstraZeneca
Enzon
opioid-induced bowel dysfunction
8 Major Healthcare Stocks Yielding At Least 3.9% With P/E Ratios Under 18
Seeking Alpha
Tue, 06/12/12 - 11:03 am
AstraZeneca
Bristol-Myers Squibb
GSK
JNJ
Eli Lilly
Merck
Novartis
Pfizer
Winners Of ASCO 2012
Seeking Alpha
Mon, 06/11/12 - 06:19 pm
ASCO
Arqule
Array Biopharma
Astex
AstraZeneca
Bristol-Myers Squibb
GSK
Curis
Exelixis
Pfizer
Immunogen
Seattle Genetics
Sanofi
Synta
Bristol-Myers, AstraZeneca announce results from Phase lll dapagliflozin study
Yahoo/The Fly On The Wall
Sun, 06/10/12 - 11:16 am
Bristol-Myers Squibb
AstraZeneca
Dapagliflozin
type 2 diabetes
diabetes
Amylin Said To Draw Bids Of $25 To $29 A Share In First Round
Bloomberg
Tue, 06/5/12 - 09:39 am
Amylin
M&A
Sanofi
AstraZeneca
Merck
Bristol-Myers Squibb
AstraZeneca bids $4bn for diabetes specialist Amylin
Telegraph, UK
Sun, 06/3/12 - 01:45 pm
AstraZeneca
Amylin
M&A
Bristol, AstraZeneca among Amylin bidders-sources
Interactive Investor
Sun, 06/3/12 - 12:23 pm
Bristol-Myers Squibb
AstraZeneca
Amylin
M&A
New Drug Could Be Game Changer For Sanofi
Seeking Alpha
Thu, 05/31/12 - 06:11 pm
Sanofi
liver cancer
GSK
AstraZeneca
Bristol-Myers Squibb
New Drug Could Push AstraZeneca 20% Higher
Seeking Alpha
Thu, 05/31/12 - 09:38 am
AstraZeneca
JNJ
Bristol-Myers Squibb
Eli Lilly
Pfizer
Sanofi
GSK
The Race For Amylin Kicks Into High-Gear
Seeking Alpha
Wed, 05/30/12 - 03:01 pm
Amylin
M&A
AstraZeneca
Bristol-Myers Squibb
Pfizer
With Plavix gone generic, payers aim to cut Effient, Brilinta
Fierce Pharma
Wed, 05/30/12 - 11:30 am
generics
Effient
Plavix
Brilinta
Eli Lilly
bloodthinners
AstraZeneca
Sanofi
Bristol-Myers Squibb
Who Should Buy Amylin?
Motley Fool
Tue, 05/29/12 - 04:44 pm
M&A
Amylin
Sanofi
Merck
Bristol-Myers Squibb
Takeda
AstraZeneca
GlaxoSmithKline and AstraZeneca Invest in Antibiotic Research
PharmaLive
Tue, 05/29/12 - 04:43 pm
antibiotic resistance
antibiotics
GSK
AstraZeneca
5 Reasons To Buy Navidea Biopharmaceuticals
Seeking Alpha
Mon, 05/21/12 - 04:37 pm
Navidea Biopharmaceuticals
AstraZeneca
AstraZeneca looks to revive experimental drugs
Financial Times, UK
Sun, 05/20/12 - 12:34 pm
AstraZeneca
R&D
AstraZeneca appeal against competition law breach and level of fine imposed on it (in Europe) should be rejected, legal advisor says
Out-Law
Sat, 05/19/12 - 12:19 pm
AstraZeneca
legal

Pages